Frazier Healthcare and Catalent Pharma Solutions have completed the purchase and sale of Catalent’s US commercial pharmaceutical packaging operations based in Philadelphia, Pennsylvania and Woodstock, Illinois to Frazier.
Catalent said that the new business will be operated as Packaging Coordinators (PCI).
Frazier Healthcare managing partner Alan Frazier said the acquisition of PCI gives the company an opportunity to extend its model of uncovering opportunities where the combination of a new management team and an infusion of capital can result in growth.
"We are demonstrating our emphasis on a team approach at Frazier by empowering a known and passionate management team to create a reinvigorated model for healthcare packaging," Frazier added.
Catalent decided to sell its US commercial packaging operations based on its business strategy to concentrate on growing its businesses in development solutions and advanced delivery technologies, clinical trial supplies, advanced blow/fill/seal aseptic delivery technology.
According to Catalent, the acquisition does not involve its Clinical Supply Services operations in Philadelphia, nor the Blow/Fill/Seal business in Woodstock.